Journal article icon

Journal article

Long-term survival with anti-PD-1-based immunotherapy, but what is the best approach?

Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1016/s1470-2045(18)30753-8

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Role:
Author
ORCID:
0000-0003-0167-1685
Publisher:
Elsevier Publisher's website
Journal:
The Lancet Oncology Journal website
Volume:
19
Issue:
11
Pages:
1424-1426
Publication date:
2018-10-22
Acceptance date:
2018-10-05
DOI:
EISSN:
1474-5488
ISSN:
1470-2045
Pubs id:
pubs:935907
URN:
uri:31259d98-108d-4b60-8d12-060c7eb96e1a
UUID:
uuid:31259d98-108d-4b60-8d12-060c7eb96e1a
Local pid:
pubs:935907
Language:
English

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP